{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:03:58Z","timestamp":1780013038281,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK118189"],"award-info":[{"award-number":["K23DK118189"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS029677"],"award-info":[{"award-number":["R01HS029677"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01-DK134347-01"],"award-info":[{"award-number":["1R01-DK134347-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R21-HD104176-01"],"award-info":[{"award-number":["1R21-HD104176-01"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1053\/j.ajkd.2025.10.006","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:12:09Z","timestamp":1768983129000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children"],"prefix":"10.1053","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-0057","authenticated-orcid":false,"given":"Chia-shi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Gbadegesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 suppl 1","key":"10.1053\/j.ajkd.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2025.02.602","article-title":"US Renal Data System 2024 annual data report: epidemiology of kidney disease in the United States","volume":"85","author":"Johansen","year":"2025","journal-title":"Am J Kidney Dis"},{"issue":"10404","key":"10.1053\/j.ajkd.2025.10.006_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","article-title":"Childhood nephrotic syndrome","volume":"402","author":"Vivarelli","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1053\/j.ajkd.2025.10.006_bib3","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1007\/s00467-022-05838-1","article-title":"The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC)","volume":"38","author":"Primack","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2025.10.006_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.13371019","article-title":"Response to first course of intensified immunosuppression in genetically stratified steroid resistant nephrotic syndrome","volume":"15","author":"Mason","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.006_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.10.006_bib6","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2215\/CJN.04780517","article-title":"An outcomes-based definition of proteinuria remission in focal segmental glomerulosclerosis","volume":"13","author":"Troost","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.006_bib8","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ekir.2025.03.027","article-title":"Risk factors for disease progression for adults and children with membranous nephropathy in the Cure Glomerulonephropathy Network (CureGN)","volume":"10","author":"Laurin","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000516832","article-title":"Racial-ethnic differences in health-related quality of life among adults and children with glomerular disease","volume":"1","author":"Krissberg","year":"2021","journal-title":"Glomerular Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2022.08.010","article-title":"Racial and ethnic disparities in acute care utilization among patients with glomerular disease","volume":"81","author":"Krissberg","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.006_bib11","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1016\/j.kint.2024.11.007","article-title":"KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children","volume":"107","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"issue":"10141","key":"10.1053\/j.ajkd.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"632.e1","DOI":"10.1016\/j.jpurol.2017.06.014","article-title":"Analyte variations in consecutive 24-hour urine collections in children","volume":"13","author":"Ellison","year":"2017","journal-title":"J Pediatr Urol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","year":"1981","journal-title":"J Pediatr"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00467-013-2483-y","article-title":"Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium","volume":"28","author":"Straatmann","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.006_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence","volume":"25","author":"Ding","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00467-018-3994-3","article-title":"Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings","volume":"33","author":"Pelletier","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2025.10.006_bib21","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00431-021-04035-w","article-title":"Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis","volume":"180","author":"Schijvens","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/adc.2007.116079","article-title":"Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial","volume":"93","author":"Abeyagunawardena","year":"2008","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1053\/j.ajkd.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","article-title":"Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Gulati","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.006_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000045684","article-title":"Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome","volume":"85","author":"Mattoo","year":"2000","journal-title":"Nephron"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.006_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s41669-022-00334-6","article-title":"Economic evaluation of using daily prednisolone versus placebo at the time of an upper respiratory tract infection for the management of children with steroid-sensitive nephrotic syndrome: a model-based analysis","volume":"6","author":"Afentou","year":"2022","journal-title":"Pharmacoecon Open"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/WTFC5658","article-title":"Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT","volume":"26","author":"Christian","year":"2022","journal-title":"Health Technol Assess"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/000992288802700807","article-title":"Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate","volume":"27","author":"Elzouki","year":"1988","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00878359","article-title":"Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome","volume":"6","author":"Srivastava","year":"1992","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.006_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","article-title":"Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"34","author":"Yadav","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.006_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ekir.2024.11.028","article-title":"Detection of antinephrin antibodies in childhood idiopathic nephrotic syndrome","volume":"10","author":"Bianchi","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2025.10.006_bib31","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00467-021-05176-8","article-title":"Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes","volume":"37","author":"Wang","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.10.006_bib32","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00467-025-06811-4","article-title":"Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022","volume":"40","author":"Denburg","year":"2025","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.006_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.kint.2025.01.019","article-title":"Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy","volume":"107","author":"Hengel","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.006_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.kint.2023.02.022","article-title":"A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants","volume":"103","author":"Malakasioti","year":"2023","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00467-021-04960-w","article-title":"APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses","volume":"36","author":"Watanabe","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.006_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/ndt\/gfw061","article-title":"APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts","volume":"32","author":"Ng","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.0000000000000069","article-title":"Rapid progression of focal segmental glomerulosclerosis in patients with high-risk APOL1 genotypes","volume":"18","author":"Kallash","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.10.006_bib39","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2147\/PPA.S371162","article-title":"Interventions incorporating therapeutic alliance to improve medication adherence in black patients with diabetes, hypertension and kidney disease: a systematic review","volume":"16","author":"Desta","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"10.1053\/j.ajkd.2025.10.006_bib40","series-title":"Pediatric Nephrology","first-page":"613","article-title":"Laboratory investigation of the child with suspected renal disease","author":"Van der Watt","year":"2016"},{"issue":"10","key":"10.1053\/j.ajkd.2025.10.006_bib41","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ndt\/gft090","article-title":"Prevention of steroid-induced low bone mineral density in children with renal diseases: a systematic review","volume":"28","author":"Gruppen","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.006_bib43","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/ndt\/gfh809","article-title":"Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements","volume":"20","author":"Gulati","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625011473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625011473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:56:06Z","timestamp":1780012566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638625011473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0272638625011473"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.10.006","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}